Stocks to Watch: Southwestern Energy Company, the Gap, Infoblox, BioMarin Pharmaceutical

Lakeway, TX -- (SBWIRE) -- 03/04/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Southwestern Energy Company (NYSE:SWN) stock increased 2.89% to $35.26. The company, on Feb. 20, reported fourth-quarter net loss of $355.6 million or $1.02 per share, compared with net income of $158.5 million or $0.45 per share last year. Adjusted earnings for the quarter were $156.4 million or $0.44 per share. Analysts on consensus estimated earnings of $0.44 per share for the quarter. The company reported fourth-quarter revenues of $773 million, compared with $744 million a year ago. Analysts estimated revenues of $712.60 million.

Additionally, Canaccord Genuity reiterated its Hold rating on Southwestern Energy and slightly raised its price target from $37.00 to $38.00.

How Should Investors Trade SWN After The Solid Jump? Let’s Find Out Here

The Gap Inc. (NYSE:GPS) stock jumped 2.89% to $33.87 after the company, on Feb. 28, announced that its Board of Directors has approved a plan to increase the company's annual dividend per share by 20 percent, from $0.50 in fiscal year 2012 to $0.60 in fiscal year 2013. The first quarterly dividend of $0.15 per share was declared for payment on or after May 1, 2013 to shareholders of record at the close of business on April 10, 2013. Additional quarterly dividends are expected to be paid in July, October, and January.

Is GPS Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Here

Infoblox Inc (NYSE:BLOX) shares increased 2.84% to $21.69. The company, on Feb. 27, announced that it has become the first and only DDI (DNS, DHCP and IP address Management) vendor to achieve Common Criteria Evaluation Assurance Level 2 (EAL-2) certification.

The company, on Feb. 21, announced expects third quarter of 2013 total net revenue in the range of $55 million to $56.5 million and Non-GAAP diluted net income per share to be in the range of $0.06 to $0.07. For fiscal 2013, it expects total net revenue in the range of $216 million to $219 million and Non-GAAP EPS to be in the range of $0.21 to $0.26. Analysts are expecting the Company to report revenues of $53 million and EPS of $0.04 for the third quarter of 2013; revenues of $208 million and EPS of $0.21 for fiscal 2013.

Is BLOX Buy After The Recent Price Movement? Find Out Here

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares increased 2.83% to $59.61. The company, on Feb. 21, said that it has entered into an agreement to license a Factor VIII gene therapy programme for the potential therapeutic treatment of haemophilia A from University College London (UCL) and St Jude Children's Research Hospital.

Additionally, the company posted fourth quarter loss of $53 million, or 43 cents per share, as compared to a loss of $26.7 million, or 23 cents per share. Revenue grew 22 percent, to $131.9 million from $107.8 million. Analysts expected a loss of 26 cents per share on $129.4 million in revenue.

Is BMRN Buy After The Recent Price Movement? Find Out Here

About vbtrendreport.com
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.